# Fasting Bioavailability Study of Zonisamide Capsules

> **NCT00685139** · PHASE1 · COMPLETED · sponsor: **Mutual Pharmaceutical Company, Inc.** · enrollment: 34 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zonisamide 100 mg Capsule
- **DRUG:** Zonisamide (Zonegran®) 100 mg Capsule

## Key facts

- **NCT ID:** NCT00685139
- **Lead sponsor:** Mutual Pharmaceutical Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2010-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685139, "Fasting Bioavailability Study of Zonisamide Capsules". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00685139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*